Annual FCF
-$27.53 M
+$4.11 M+12.98%
31 December 2023
Summary:
Tempest Therapeutics annual free cash flow is currently -$27.53 million, with the most recent change of +$4.11 million (+12.98%) on 31 December 2023. During the last 3 years, it has fallen by -$1.44 million (-5.50%). TPST annual FCF is now -44.37% below its all-time high of -$19.07 million, reached on 31 December 2020.TPST Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$10.20 M
-$4.44 M-77.06%
30 September 2024
Summary:
Tempest Therapeutics quarterly free cash flow is currently -$10.20 million, with the most recent change of -$4.44 million (-77.06%) on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-64.95%). TPST quarterly FCF is now -17989.47% below its all-time high of $57.00 thousand, reached on 30 June 2021.TPST Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$29.49 M
-$3.71 M-14.39%
30 September 2024
Summary:
Tempest Therapeutics TTM free cash flow is currently -$29.49 million, with the most recent change of -$3.71 million (-14.39%) on 30 September 2024. Over the past year, it has dropped by -$1.97 million (-7.14%). TPST TTM FCF is now -370.59% below its all-time high of -$6.27 million, reached on 30 June 2021.TPST TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -65.0% | -7.1% |
| 3 y3 years | -5.5% | -27.3% | -13.0% |
| 5 y5 years | - | - | - |
TPST Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.5% | +13.0% | -77.1% | at low | -14.4% | +16.8% |
| 5 y | 5 years | -44.4% | +13.0% | <-9999.0% | +13.7% | -370.6% | +16.8% |
| alltime | all time | -44.4% | +13.0% | <-9999.0% | +13.7% | -370.6% | +16.8% |
Tempest Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.20 M(+77.1%) | -$29.49 M(+14.4%) |
| June 2024 | - | -$5.76 M(-21.7%) | -$25.78 M(-2.8%) |
| Mar 2024 | - | -$7.35 M(+19.0%) | -$26.53 M(-3.6%) |
| Dec 2023 | -$27.53 M(-13.0%) | -$6.18 M(-4.7%) | -$27.53 M(-2.3%) |
| Sept 2023 | - | -$6.49 M(-0.3%) | -$28.18 M(-8.7%) |
| June 2023 | - | -$6.51 M(-22.0%) | -$30.87 M(-6.1%) |
| Mar 2023 | - | -$8.35 M(+22.2%) | -$32.87 M(+3.9%) |
| Dec 2022 | -$31.63 M | -$6.83 M(-25.5%) | -$31.63 M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$9.18 M(+7.9%) | -$32.81 M(-7.4%) |
| June 2022 | - | -$8.51 M(+19.7%) | -$35.44 M(+31.9%) |
| Mar 2022 | - | -$7.11 M(-11.3%) | -$26.88 M(+3.0%) |
| Dec 2021 | -$26.09 M(+36.8%) | -$8.01 M(-32.2%) | -$26.09 M(+44.3%) |
| Sept 2021 | - | -$11.81 M(<-9900.0%) | -$18.08 M(+188.5%) |
| June 2021 | - | $57.00 K(-100.9%) | -$6.27 M(-0.9%) |
| Mar 2021 | - | -$6.32 M | -$6.32 M |
| Dec 2020 | -$19.07 M | - | - |
FAQ
- What is Tempest Therapeutics annual free cash flow?
- What is the all time high annual FCF for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly FCF year-on-year change?
- What is Tempest Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Tempest Therapeutics?
- What is Tempest Therapeutics TTM FCF year-on-year change?
What is Tempest Therapeutics annual free cash flow?
The current annual FCF of TPST is -$27.53 M
What is the all time high annual FCF for Tempest Therapeutics?
Tempest Therapeutics all-time high annual free cash flow is -$19.07 M
What is Tempest Therapeutics quarterly free cash flow?
The current quarterly FCF of TPST is -$10.20 M
What is the all time high quarterly FCF for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly free cash flow is $57.00 K
What is Tempest Therapeutics quarterly FCF year-on-year change?
Over the past year, TPST quarterly free cash flow has changed by -$4.01 M (-64.95%)
What is Tempest Therapeutics TTM free cash flow?
The current TTM FCF of TPST is -$29.49 M
What is the all time high TTM FCF for Tempest Therapeutics?
Tempest Therapeutics all-time high TTM free cash flow is -$6.27 M
What is Tempest Therapeutics TTM FCF year-on-year change?
Over the past year, TPST TTM free cash flow has changed by -$1.97 M (-7.14%)